3.13
Insufficienza respiratoria acuta III: Insufficienza respiratoria ipercapnica
L'insufficienza respiratoria ipercapnica, nota anche come insufficienza respiratoria di tipo 2 o ventilatoria, è una grave condizione caratterizzata d…
L'insufficienza respiratoria di tipo 2 o ipercapnica si verifica a causa dell'aumento della produzione di anidride carbonica o della diminuzione della ventilazione alveolare.
È caratterizzata da anidride carbonica arteriosa o PaCO2 superiore a 45 mmHg e un pH inferiore a 7,35.
Le condizioni che causano insufficienza respiratoria ipercapnica possono essere classificate in quattro gruppi.
In primo luogo, le anomalie delle vie aeree e degli alveoli come l'asma e la fibrosi cistica possono portare all'ostruzione delle vie aeree o all'intrappolamento dell'aria, richiedendo un maggiore sforzo inspiratorio per un volume corrente sufficiente.
Provoca affaticamento dei muscoli respiratori ed eventuale insufficienza ventilatoria.
Successivamente, le anomalie del sistema nervoso centrale, come le overdose da oppioidi, sopprimono la spinta respiratoria riducendo la sensibilità del tronco cerebrale all'anidride carbonica, portando a livelli elevati di PaCO2.
Inoltre, le anomalie della parete toracica, come il torace a flagello, limitano il movimento polmonare e diaframmatico a causa del dolore e della restrizione meccanica dovuta alle fratture costali.
Infine, le malattie neuromuscolari come la sindrome di Guillain-Barré possono causare debolezza o paralisi dei muscoli respiratori.
Quando i muscoli respiratori sono compromessi, non riescono a mantenere i normali livelli di PaCO2, portando a insufficienza respiratoria.
View the full transcript and gain access to JoVE Core videos
Q1: What defines Type 2 or hypercapnic respiratory failure?
Type 2 respiratory failure, also called hypercapnic or ventilatory failure, occurs when the body cannot effectively remove carbon dioxide. It is characterized by arterial CO2 pressure (PaCO2) exceeding 45 mmHg and blood pH below 7.35. This indicates ventilatory demand surpasses the body's supply, meaning the ventilation needed to maintain normal PaCO2 levels exceeds what respiratory muscles can achieve without fatigue.
Q2: How do airway and alveoli abnormalities cause hypercapnic respiratory failure?
Conditions like asthma and cystic fibrosis cause airway obstruction or air trapping, requiring increased inspiratory effort to achieve sufficient tidal volume. This heightened work of breathing leads to respiratory muscle fatigue and eventual ventilatory failure, preventing adequate carbon dioxide elimination and resulting in elevated PaCO2 levels.
Q3: Why do central nervous system problems contribute to hypercapnic respiratory failure?
Central nervous system abnormalities, such as opioid overdoses or brainstem injuries, suppress the breathing drive by reducing the brainstem's sensitivity to carbon dioxide. When the medulla, the respiratory control center, cannot correctly sense and respond to CO2 changes, the body fails to maintain adequate ventilation, leading to elevated PaCO2 and respiratory failure.
Q4: What role do neuromuscular disorders play in developing hypercapnic respiratory failure?
Neuromuscular diseases like Guillain-Barré syndrome cause respiratory muscle weakness or paralysis. When respiratory muscles are compromised, they cannot maintain normal PaCO2 levels or generate sufficient ventilatory force. This severely limits the body's ability to eliminate carbon dioxide, directly contributing to ventilatory failure and hypercapnia.
Q5: How do chest wall abnormalities impair ventilation and cause respiratory failure?
Chest wall abnormalities such as flail chest, severe obesity, or kyphoscoliosis restrict chest and diaphragm movement due to pain or mechanical restriction from rib fractures. These conditions impair normal lung expansion and adequate ventilation, drastically reducing ventilatory supply and compromising the body's ability to eliminate carbon dioxide effectively.
Q6: Can diabetic ketoacidosis lead to hypercapnic respiratory failure?
Yes. Diabetic ketoacidosis causes metabolic acidosis, triggering rapid, deep breathing (Kussmaul respirations) as a compensatory mechanism. However, if the body becomes exhausted or has an underlying lung condition, this compensation fails, resulting in carbon dioxide retention and hypercapnic respiratory failure requiring urgent medical attention.
Q7: What management approach is essential for hypercapnic respiratory failure?
Management requires close monitoring of respiratory symptoms and carbon dioxide levels, with prompt intervention when breathing difficulty increases. A comprehensive, multidisciplinary approach involving respiratory therapists, neurologists, and pulmonologists aims to treat the underlying cause, enhance ventilation, and provide mechanical ventilatory support when necessary to ensure adequate oxygenation and pneumonia nursing management and prevention.